Drawing for BINX

USPTO serial 88103934

BINX

Reviewed by CopyMark Law Group

Reg. 5933360Status 705Registered
Filing date
Status date
Registration date
Dec 10, 2019
Examiner
CROWLEY, SEAN MICHAEL
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 705 means a Madrid-based U.S. registration has accepted Section 71 maintenance and Section 15 incontestability. The U.S. extension is active with strengthened rights. Track next renewal deadlines in TSDR and WIPO records.

Status 705: Status 705 means a Madrid-based U.S. registration has accepted Section 71 maintenance and Section 15 incontestability. The U.S. extension is active with strengthened rights.

Need help with BINX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Kimberly B. Herman

Kimberly B. Herman Sullivan & Worcester LLPOne Post Office SquareBoston, MA 02109United States

Goods and services

ClassDescriptionStatusFirst use
005Medical conditions screening kits composed of medical diagnostic reagents and assays for testing of bodily fluids for use in detection STD's and human papillomavirus and prostate-specific antigen, the aforementioned being for use in testing for the presence of infection and disease state health markers in human samples in clinical applications, in animal samples in veterinary applications, and in testing for the presence of infection-causing microorganisms in environmental applicationsACTIVEOct 8, 2018
010Medical diagnostic kits for medical purposes consisting of medical specimen collection devices for testing the presence of biomarkers indicative of disease, medical conditions and levels of substances, namely, STDs, cancer genetic markers, fertility, and lifestyle concerns; Instrument and apparatus system for medical diagnostic use consisting of medical specimen collection devices, an electronic instrument, a disposable cartridge on which the test is performed in conjunction with the instrument and a range of medical devices used for sample collection to provide the test material, all sold to be used as a unit; the aforementioned systems are for use in testing for the presence of infection and disease state health markers in human samples in clinical applications, in animal samples in veterinary applications, and in testing for the presence of infection-causing microorganisms in environmental applicationsACTIVEOct 8, 2018
044[ Medical testing for diagnostic or treatment purposes; medical diagnostic testing, monitoring, and reporting services; medical diagnostic testing for biomarkers indicative of disease, STDs, cancer, genetic anomalies and disorders, fertility, and lifestyle issues, namely, collecting biological samples for in-home testing for medical purposes, providing testing and diagnostic services thereto for medical purposes, and medical information services, namely, reporting test results to customers test kits ]SECTION 8 - CANCELLEDOct 8, 2018

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 11, 2026NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Mar 11, 2026C15PREGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Mar 11, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Dec 9, 2025E815TEAS SECTION 8 & 15 RECEIVED—
Feb 21, 2025EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Feb 21, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 21, 2025ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Feb 21, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 21, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 11, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 11, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 11, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 10, 2024REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Oct 16, 2024ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
May 6, 2024EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
May 6, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 6, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 6, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 2, 2024EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Feb 2, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 2, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 2, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 14, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 14, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 14, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 14, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jun 14, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Apr 22, 2021ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Mar 1, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Mar 1, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 1, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 1, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 1, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Aug 13, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Aug 13, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 13, 2020EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Aug 13, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 13, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 13, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Dec 10, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 6, 2019SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Nov 5, 2019CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Sep 12, 2019SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Sep 12, 2019AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Aug 14, 2019IUAFUSE AMENDMENT FILED—
Aug 14, 2019EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Feb 26, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jan 1, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 1, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 12, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 28, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 28, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 28, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 27, 2018PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Nov 21, 2018CEPECOMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED—
Nov 21, 2018ALIEASSIGNED TO LIE—
Nov 21, 2018GEANNOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Nov 21, 2018GEAPEXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Nov 21, 2018CPEAEXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED—
Nov 21, 2018DOCKASSIGNED TO EXAMINER—
Sep 13, 2018MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Sep 12, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—

Frequently asked questions

Related guidance